Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-23-011387

President and CEO sold 27,750 shares at an average $27.23 ($755,517)

  • President and CEO disposed of 164,898 shares (other)
  • President and CEO acquired 164,898 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
SCANGOS GEORGE A President and CEO 2022-12-21 Other disposition −49,984 827,151 I
SCANGOS GEORGE A President and CEO 2022-12-21 Other acquisition +49,984 111,644 I
SCANGOS GEORGE A President and CEO 2022-12-21 Other disposition −49,984 827,151 I
SCANGOS GEORGE A President and CEO 2022-12-21 Other acquisition +49,984 111,644 I
SCANGOS GEORGE A President and CEO 2023-01-18 Other disposition −64,930 3,533,629 I
SCANGOS GEORGE A President and CEO 2023-01-18 Other acquisition +64,930 179,930 I
SCANGOS GEORGE A President and CEO 2023-02-17 Sale −9,894 $25.29 $250,199 214,095 D
SCANGOS GEORGE A President and CEO 2023-02-21 Sale −11,382 $28.02 $318,867 202,713 D
SCANGOS GEORGE A President and CEO 2023-02-21 Sale −6,474 $28.80 $186,451 196,239 D
Open-market sales · 27,750 sh · avg $27.23 · $755,517
Loading xslF345X03/doc4.xml…